Valle Soria-De
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.
Journal: Leukemia
Published: March 05, 2026
Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results.
Journal: Leukemia
Published: February 21, 2025
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation.
Journal: Nature biotechnology
Published: July 10, 2023
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results.
Journal: Leukemia
Published: December 02, 2022
Dasatinib-induced spleen contraction leads to transient lymphocytosis.
Journal: Blood advances
Published: November 02, 2022
Monitoring and safety of CAR-T therapy in clinical practice.
Journal: Expert opinion on drug safety
Published: September 14, 2021
Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease.
Journal: Nature communications
Published: August 12, 2019
Evaluation of therapeutic targeting of CCR7 in acute graft-versus-host disease.
Journal: Bone marrow transplantation
Published: July 18, 2019
A high migratory capacity of donor T-cells in response to the lymph node homing receptor CCR7 increases the incidence and severity of GvHD.
Journal: Bone marrow transplantation
Published: July 19, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026